oktober 2, 2022

CCT251545 Analogue, Compound 51

CCT251545 Analogue, Compound 51 

To Order Contact us: bjorn@lembcke.dk

INCB024360 analogue

A3493-25 25 mg
EUR 293
Description: INCB024360 analogue is a potent and selective inhibitor of IDO1 with IC50 value of 67 nM. [1]IDO (indoleamine-pyrrole 2, 3-dioxygenase) is an enzyme which is encoded by the IDO1 gene.

INCB024360 analogue

A3493-5 5 mg
EUR 131
Description: INCB024360 analogue is a potent and selective inhibitor of IDO1 with IC50 value of 67 nM. [1]IDO (indoleamine-pyrrole 2, 3-dioxygenase) is an enzyme which is encoded by the IDO1 gene.

INCB024360 analogue

A3493-5.1 10 mM (in 1mL DMSO)
EUR 151
Description: INCB024360 analogue is a potent and selective inhibitor of IDO1 with IC50 value of 67 nM. [1]IDO (indoleamine-pyrrole 2, 3-dioxygenase) is an enzyme which is encoded by the IDO1 gene.

INCB024360 analogue

A3493-50 50 mg
EUR 415
Description: INCB024360 analogue is a potent and selective inhibitor of IDO1 with IC50 value of 67 nM. [1]IDO (indoleamine-pyrrole 2, 3-dioxygenase) is an enzyme which is encoded by the IDO1 gene.

Phentolamine Analogue 1

HY-U00404 5mg
EUR 877

Macitentan (n-butyl analogue)

HY-14184A 10mM/1mL
EUR 317

Compound E

HY-14176 10mM/1mL
EUR 694

Compound 401

HY-19341 10mM/1mL
EUR 186

Compound 2

HY-U00358 10mg
EUR 6041

Compound 34

GL2080-1MG 1 mg
EUR 373

Compound 34

GL2080-200UG 200 ug
EUR 166

Compound 112254

GL3740-10MG 10 mg
EUR 166

Compound 112254

GL3740-50MG 50 mg
EUR 459

Compound E

GL3746-1MG 1 mg
EUR 378

Compound E

GL3746-250UG 250 ug
EUR 172

Compound E

GL3746-5MG 5 mg
EUR 998

Imidazoquinoline Compound

VAdv-Ly0028 5 mg
EUR 3280
Description: Imidazoquinoline compound, a TLR7 agonist vaccine adjuvant.

Compound CL0485

ADC-P-074 unit Ask for price

Compound K

N1890-20 20 mg
EUR 340
Description: Compound K

Compound 56

A8197-.5 500 µg
EUR 108
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56

A8197-5 5 mg
EUR 224
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56

A8197-5.1 10 mM (in 1mL DMSO)
EUR 270
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56

A8197-S Evaluation Sample
EUR 81
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 401

B7337-10 10 mg
EUR 224

Compound 401

B7337-25 25 mg
EUR 441

Compound 401

B7337-5 5 mg
EUR 180

Compound W

A4401-50 50 mg
EUR 177
Description: Inhibitor of ?-secretase; causes a decrease in the released levels of A?42 and notch-1 A?-like peptide 25 (N?25).

Compound 401

1657-5
EUR 238

Compound 1

1688-5
EUR 207

Compound 34

1898-1000
EUR 457

Compound 34

1898-200
EUR 158

Compound E

1949-1000
EUR 370

Compound E

1949-250
EUR 153

Compound W

2208-250
EUR 300

Compound W

2208-50
EUR 115

Compound 112254

2573-25
EUR 588

Compound 112254

2573-5
EUR 185

ss-DNA (Single-stranded DNA Antibody IgG) ELISA test

51 96T/Box Ask for price
Description: ELISA based test for quantitative detection of ss-DNA (Single-stranded DNA Antibody IgG)

APHA Compound 8

M45003 1 mg
EUR 284.9
Description: Ask the seller for details

Teijin compound 1

HY-108323 5mg
EUR 312

Antibacterial compound 2

HY-101730 5mg
EUR 7984

Antibacterial compound 1

HY-101819 5mg
EUR 2198

Antiasthmatic Compound 1

HY-U00409 1mg
EUR 849

Compound 112254 hydrochloride

GL8859-10MG 10 mg
EUR 166

Compound 112254 hydrochloride

GL8859-50MG 50 mg
EUR 459

Dorsomorphin (Compound C)

B3252-10 10 mg
EUR 137
Description: Dorsomorphin is a cell-permeable and reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with Ki value of 109nM [1].Dorsomorphin is highly selective against AMPK over other structure related kinases such as protein kinase A, protein kinase C and Janus kinase 3.

Dorsomorphin (Compound C)

B3252-5 5 mg
EUR 108
Description: Dorsomorphin is a cell-permeable and reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with Ki value of 109nM [1].Dorsomorphin is highly selective against AMPK over other structure related kinases such as protein kinase A, protein kinase C and Janus kinase 3.

Dorsomorphin (Compound C)

B3252-50 50 mg
EUR 340
Description: Dorsomorphin is a cell-permeable and reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with Ki value of 109nM [1].Dorsomorphin is highly selective against AMPK over other structure related kinases such as protein kinase A, protein kinase C and Janus kinase 3.

Teijin compound 1

B5468-10 10 mg
EUR 389

Teijin compound 1

B5468-50 50 mg
EUR 1476

GPR120 Compound A

C5824-10 10 mg
EUR 293
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

GPR120 Compound A

C5824-5 5 mg
EUR 197
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

GPR120 Compound A

C5824-50 50 mg
EUR 920
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

Ro 51

B5572-10 10 mg
EUR 389

Ro 51

B5572-50 50 mg
EUR 1476

NCH 51

A4495-10 10 mg
EUR 231
Description: NCH 51 is a potent and novel inhibitor of histone deacetylase [1]. Histone deacetylases (HADC) are a series of enzymes that remove acetyl groups from an ?-N-acetyl lysine amino acid on a histone and make the histones to wrap the DNA more tightly, which prevent transcription.

NCH 51

A4495-5.1 10 mM (in 1mL DMSO)
EUR 200
Description: NCH 51 is a potent and novel inhibitor of histone deacetylase [1]. Histone deacetylases (HADC) are a series of enzymes that remove acetyl groups from an ?-N-acetyl lysine amino acid on a histone and make the histones to wrap the DNA more tightly, which prevent transcription.

NCH 51

A4495-50 50 mg
EUR 857
Description: NCH 51 is a potent and novel inhibitor of histone deacetylase [1]. Histone deacetylases (HADC) are a series of enzymes that remove acetyl groups from an ?-N-acetyl lysine amino acid on a histone and make the histones to wrap the DNA more tightly, which prevent transcription.

NCH 51

B1130-25
EUR 457

NCH 51

B1130-5
EUR 153

Arrhythmias-Targeting Compound 1

HY-101750 20mg
EUR 5683

NPS ALX Compound 4a

HY-103090 5mg
EUR 291

Cancer-Targeting Compound 1

HY-U00300 1mg
EUR 849

Neuromuscular-targeting compound 1

HY-U00310 20mg
EUR 4803

Itch-Targeting Compound 1

HY-U00361 20mg
EUR 11180

Arrhythmic-Targeting Compound 1

HY-U00393 5mg
EUR 9361

Asthma relating compound 1

HY-U00412 5mg
EUR 2846

8-hydroxy Guanosine, compound

8OHG15-N-1 1 mg
EUR 202

8-hydroxy Guanosine, compound

8OHG15-N-5 5 mg
EUR 590

DiscoveryProbe? Bioactive Compound Library

L1022-.1 100 uL/well(10 mM solution)
EUR 23389

DiscoveryProbe? Bioactive Compound Library

L1022-.25 250 uL/well(10 mM solution)
EUR 42042

DiscoveryProbe? Bioactive Compound Library

L1022-5 5 mg/well
EUR 54686

DiscoveryProbe? GPCR Compound Library

L1025-.1 100 uL/well(10 mM solution)
EUR 4736

DiscoveryProbe? GPCR Compound Library

L1025-.25 250 uL/well(10 mM solution)
EUR 8518

DiscoveryProbe? GPCR Compound Library

L1025-5 5 mg/well
EUR 11070

DiscoveryProbe? Epigenetics Compound Library

L1029-.1 100 uL/well(10 mM solution)
EUR 5954

DiscoveryProbe? Epigenetics Compound Library

L1029-.25 250 uL/well(10 mM solution)
EUR 10722

DiscoveryProbe? Epigenetics Compound Library

L1029-5 5 mg/well
EUR 13970

DiscoveryProbe? Autophagy Compound Library

L1031-.1 100 uL/well(10 mM solution)
EUR 11174

DiscoveryProbe? Autophagy Compound Library

L1031-.25 250 uL/well(10 mM solution)
EUR 20118

DiscoveryProbe? Autophagy Compound Library

L1031-5 5 mg/well
EUR 26150

DiscoveryProbe? Apoptosis Compound Library

L1036-.1 100 uL/well(10 mM solution)
EUR 3472

DiscoveryProbe? Apoptosis Compound Library

L1036-.25 250 uL/well(10 mM solution)
EUR 6198

DiscoveryProbe? Apoptosis Compound Library

L1036-5 5 mg/well
EUR 8054

PKM2 inhibitor(compound 3k)

B8217-25 25 mg
EUR 412

PKM2 inhibitor(compound 3k)

B8217-5 5 mg
EUR 168

Tissue Tek O.C.T. Compound

4583 125ml
EUR 90

Immunoglobulin Lambda Variable 1-51 (IGLV1-51) Antibody

20-abx339501
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul

Immunoglobulin Lambda Variable 1-51 (IGLV1-51) Antibody

20-abx211170
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul

IGLV1-51 Antibody

1-CSB-PA278626
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against IGLV1-51. Recognizes IGLV1-51 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

IGLV1-51 Antibody

1-CSB-PA827496
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against IGLV1-51. Recognizes IGLV1-51 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

AGRP (25-51)

5-00631 4 x 1mg Ask for price

pQE- 51 Plasmid

PVT0529 2 ug
EUR 325

175991-51-2

TBZ0677 unit Ask for price

Imidazol-1-yl compound 1

HY-U00322 10mg
EUR 3700

CCT251545 Analogue, Compound 51